PMDA drug package insert
ストルピンMカプセル
PMDA OTC drug · 芳香園製薬（株） · package insert Dec 7, 2024
Key facts
| Brand names | ストルピンMカプセル |
|---|---|
| Companies | 製造販売元／日本薬品株式会社,販売会社／（株）宝仙堂,販売会社／あかひげ薬局,販売会社／富山薬品（株）,販売会社／芳香園製薬（株） |
| Product type | OTC drug |
| OTC risk class | 要指導医薬品 |
| OTC dosage form | カプセル |
| OTC effect category | その他の泌尿生殖器官及び肛門用薬 |
| Package insert date | Dec 7, 2024 |
| PMDA document key | 530370_J0601003774 |
| PMDA company code | 530370 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: